These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3660187)

  • 1. [High-dose cytosine arabinoside and L-asparaginase in the treatment of refractory or recurrent acute non-lymphoblastic leukemia].
    Sanz MA; Borrego D; Martín-Aragonés G; Martínez JA; Lorenzo I; Sanz G; Sayas MJ; Jarque I; Pastor E; Rafecas J
    Sangre (Barc); 1987; 32(4):476-81. PubMed ID: 3660187
    [No Abstract]   [Full Text] [Related]  

  • 2. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intermediate-dose cytosine arabinoside therapy in refractory acute leukemia].
    Ohshima A; Yoshida K; Miyazaki S; Fukushima Y; Miura AB; Endo K; Ando H; Sasaki H; Saito S; Sato I
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):139-42. PubMed ID: 2643393
    [No Abstract]   [Full Text] [Related]  

  • 4. A single, high dose of idarubicin combined with cytarabine as induction therapy for adult patients with recurrent or refractory acute lymphoblastic leukemia.
    Weiss MA; Aliff TB; Tallman MS; Frankel SR; Kalaycio ME; Maslak PG; Jurcic JG; Scheinberg DA; Roma TE
    Cancer; 2002 Aug; 95(3):581-7. PubMed ID: 12209751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sequential high-dose cytosine arabinoside and L-asparaginase in childhood leukemia in relapse.
    Ettinger LJ; Biener R; Finklestein JZ; Kamalakar P; Jones GR; Avramis VI; Holcenberg JS
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):155-9. PubMed ID: 3859930
    [No Abstract]   [Full Text] [Related]  

  • 6. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
    Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intermediate-dose cytosine arabinoside in combination with mitoxantrone in the treatment of refractory leukemia].
    Takeyama H; Fukutani H; Takeo T; Yamada H; Watanabe E
    Rinsho Ketsueki; 1988 Jul; 29(7):1050-4. PubMed ID: 3184471
    [No Abstract]   [Full Text] [Related]  

  • 8. Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemia.
    Karbasian-Esfahani M; Wiernik PH; Novik Y; Paietta E; Dutcher JP
    Cancer; 2004 Sep; 101(6):1414-9. PubMed ID: 15368329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparison of 2 regimens of polychemotherapy in refractory acute leukemia or in relapse].
    Borbolla-Escoboza JR; López-Hernández MA; González-Avante M; DeDiego J; Trueba-Christy E; Anaya-Cuéllar I
    Rev Invest Clin; 1998; 50(4):307-10. PubMed ID: 9830318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential high-dose cytosine arabinoside-asparaginase treatment in advanced childhood leukemia.
    Wells RJ; Feusner J; Devney R; Woods WG; Provisor AJ; Cairo MS; Odom LF; Nachman J; Jones GR; Ettinger LJ
    J Clin Oncol; 1985 Jul; 3(7):998-1004. PubMed ID: 3860629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of a case of childhood acute non-lymphocytic leukemia (ANLL) using high-dose cytosine arabinoside for intensification of early therapy].
    Imashuku S; Nakajima T; Morimoto S; Hibi S; Todo S; Morioka Y; Sugimoto T
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):527-30. PubMed ID: 3813580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of high-risk acute lymphoblastic leukemia in children using the AL851 and ALHR88 protocols: a report from the Kyushu-Yamaguchi Children's Cancer Study Group in Japan.
    Matsuzaki A; Ishii E; Okamura J; Eguchi H; Yoshida N; Yanai F; Inoue T; Miyake K; Ishihara T; Tsuboi C
    Med Pediatr Oncol; 1996 Jan; 26(1):10-9. PubMed ID: 7494507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective combination treatment of advanced acute lymphocytic leukemia with cytosine arabinoside (NSC-63878) and L-asparaginase (NSC-109229).
    Ortega JA; Finklestein JZ; Ertel I; Hammond D; Karon M
    Cancer Chemother Rep; 1972 Jun; 56(3):363-8. PubMed ID: 19051496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract]   [Full Text] [Related]  

  • 15. Methotrexate followed by L-asparaginase for the treatment of acute non lymphoid leukemia.
    Tribalto M; Amadori S; Avvisati G; Del Bianco P; Franchi A; Gallerano T; Papa G; Mandelli F
    Haematologica; 1985; 70(4):319-23. PubMed ID: 3935530
    [No Abstract]   [Full Text] [Related]  

  • 16. [Induction of cellular differentiation in the treatment of acute leukemias: preliminary report of the use of low doses of cytosine arabinoside for the induction of remission].
    Marín-López A; Lobato-Mendizábal E; Munive-Ordóñez I; Ruiz-Argüelles GJ
    Rev Invest Clin; 1984; 36(3):247-51. PubMed ID: 6515157
    [No Abstract]   [Full Text] [Related]  

  • 17. All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.
    Al Bahar S; Pandita R; Bavishi K; Kreze O
    Indian J Cancer; 2004; 41(3):125-8. PubMed ID: 15472411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimetabolite-based therapy in childhood T-cell acute lymphoblastic leukemia: a report of POG study 9296.
    Winter SS; Holdsworth MT; Devidas M; Raisch DW; Chauvenet A; Ravindranath Y; Ducore JM; Amylon MD
    Pediatr Blood Cancer; 2006 Feb; 46(2):179-86. PubMed ID: 16007607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High-dose treatment].
    Takaku F
    Gan To Kagaku Ryoho; 1985 Apr; 12(4):830-8. PubMed ID: 3872631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.